Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

January 1, 2025; Volume 66,Issue 1

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 6A;

Discussions with Leaders

  • You have access
    Solving Challenging Puzzles
    Heather Jacene and Johannes Czernin
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 1-3; DOI: https://doi.org/10.2967/jnumed.124.269029

The State of the Art

  • Nuclear Cardiology Surrogate Biomarkers in Clinical Trials
    You have access
    Nuclear Cardiology Surrogate Biomarkers in Clinical Trials
    Robert J.H. Miller, Krishna K. Patel, Jacek Kwiecinski, Leandro Slipczuk, Marc Dweck, David E. Newby, Panithaya Chareonthaitawee and Piotr Slomka
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 4-11; DOI: https://doi.org/10.2967/jnumed.124.267869

Hot Topics

  • You have access
    Imaging of the Aging Human Brain
    Yan Zhong, Chentao Jin, Xiaofeng Dou, Rui Zhou, Mei Tian and Hong Zhang
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 12-13; DOI: https://doi.org/10.2967/jnumed.124.268451

Focus on Molecular Imaging

  • Open Access
    Molecular Imaging of Cancer Stem Cells and Their Role in Therapy Resistance
    Sofia N. dos Santos and Timothy H. Witney
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 14-19; DOI: https://doi.org/10.2967/jnumed.124.267657

Is It Really Happening?

  • You have access
    Is Routine Dosimetry Really Happening?
    John J. Sunderland
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 20-23; DOI: https://doi.org/10.2967/jnumed.124.267830

Editorial

  • You have access
    Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands
    Nathalie L. Albert, Matthias Preusser, Norbert Galldiks and Jana Ivanidze
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 24-25; DOI: https://doi.org/10.2967/jnumed.124.268314

Oncology

  • Clinical

    • PRACTICE STANDARDS

      • Open Access
        SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET
        Thomas A. Hope, Jeremie Calais, Ajit H. Goenka, Uwe Haberkorn, Mark Konijnenberg, Jonathan McConathy, Daniela E. Oprea-Lager, Laura Trimnal, Elcin Zan, Ken Herrmann and Christophe M. Deroose
        Journal of Nuclear Medicine January 1, 2025, 66 (1) 26-33; DOI: https://doi.org/10.2967/jnumed.124.269002
    • [<sup>18</sup>F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [<sup>18</sup>F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status
      You have access
      [18F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [18F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status
      Joanna K. Weeks, Austin R. Pantel, Sarah B. Gitto, Fang Liu, Erin K. Schubert, Daniel A. Pryma, Michael D. Farwell, David A. Mankoff, Robert H. Mach, Fiona Simpkins and Lilie L. Lin
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 34-39; DOI: https://doi.org/10.2967/jnumed.124.267627
  • Basic

    • Preclinical Evaluation and Pilot Clinical Study of CD137 PET Radiotracer for Noninvasive Monitoring Early Responses of Immunotherapy
      You have access
      Preclinical Evaluation and Pilot Clinical Study of CD137 PET Radiotracer for Noninvasive Monitoring Early Responses of Immunotherapy
      Kai Cheng, Luna Ge, Miaomiao Song, Wanhu Li, Jinsong Zheng, Jingru Liu, Yuxi Luo, Pengfei Sun, Shengnan Xu, Zhen Cheng, Jinming Yu and Jie Liu
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 40-46; DOI: https://doi.org/10.2967/jnumed.124.268068

Theranostics

  • Clinical

    • PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received <sup>177</sup>Lu-PSMA-617: Importance of <sup>18</sup>F-FDG–Avid Discordant Findings
      You have access
      PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177Lu-PSMA-617: Importance of 18F-FDG–Avid Discordant Findings
      Ridvan Arda Demirci, Alireza Ghodsi, Roman Gulati, Sanaz Behnia, Peter S. Nelson, Heather H. Cheng, Todd A. Yezefski, Michael C. Haffner, Jessica E. Hawley, Robert B. Montgomery, Evan Y. Yu, Michael T. Schweizer, Delphine L. Chen and Amir Iravani
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 47-53; DOI: https://doi.org/10.2967/jnumed.124.268167
    • Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET—An International Multicenter Retrospective Study
      You have access
      Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET—An International Multicenter Retrospective Study
      Lena M. Unterrainer, Thomas A. Hope, Wolfgang P. Fendler, Tristan Grogan, Honest Ndlovu, Wesley Armstrong, Francesco Barbato, Matthias R. Benz, Matthew B. Rettig, Amar U. Kishan, Mike Sathekge, Ken Herrmann, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 54-60; DOI: https://doi.org/10.2967/jnumed.124.268441
    • Real-World Comparison of Cabazitaxel Versus <sup>177</sup>Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer
      You have access
      Real-World Comparison of Cabazitaxel Versus 177Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer
      Mike Wenzel, Florestan Koll, Benedikt Hoeh, Clara Humke, Carolin Siech, Nicolai Mader, Amir Sabet, Daniel Groener, Thomas Steuber, Markus Graefen, Tobias Maurer, Christian Brandts, Severine Banek, Felix K.H. Chun and Philipp Mandel
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 61-66; DOI: https://doi.org/10.2967/jnumed.124.268807
    • Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery
      You have access
      Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery
      Lilit Schweiger, Tobias Maurer, Ricarda Simon, Thomas Horn, Matthias Heck, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 67-72; DOI: https://doi.org/10.2967/jnumed.124.268151
    • INVITED PERSPECTIVE

      • You have access
        Perspective on Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery
        Roberto C. Delgado Bolton
        Journal of Nuclear Medicine January 1, 2025, 66 (1) 73-74; DOI: https://doi.org/10.2967/jnumed.124.268783
    • Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care System
      You have access
      Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care System
      Sean R. Miller, Rachel Tucker Gonzalez, William C. Jackson, Megan E.V. Caram, Phoebe A. Tsao, Kristian Stensland, Yashesh Shah, Daniel Wale, Ka Kit Wong, Benjamin L. Viglianti, David Elliott, Tanner Caverly, Timothy P. Hofer, Sameer Saini, Michael D. Green, Matthew Schipper, Robert T. Dess and Alex K. Bryant
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 75-83; DOI: https://doi.org/10.2967/jnumed.124.268555
  • Basic

    • Mathematic Modeling of Tumor Growth During [<sup>177</sup>Lu]Lu-PSMA Therapy: Insights into Treatment Optimization
      You have access
      Mathematic Modeling of Tumor Growth During [177Lu]Lu-PSMA Therapy: Insights into Treatment Optimization
      Nouran R.R. Zaid, Remco Bastiaannet, Rob Hobbs and George Sgouros
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 84-90; DOI: https://doi.org/10.2967/jnumed.124.268457

Radionuclide Therapy

  • Localized In Vivo Prodrug Activation Using Radionuclides
    Open Access
    Localized In Vivo Prodrug Activation Using Radionuclides
    Jeremy M. Quintana, Fangchao Jiang, Mikyung Kang, Victor Valladolid Onecha, Arda Könik, Lei Qin, Victoria E. Rodriguez, Huiyu Hu, Nicholas Borges, Ishaan Khurana, Leou I. Banla, Mariane Le Fur, Peter Caravan, Jan Schuemann, Alejandro Bertolet, Ralph Weissleder, Miles A. Miller and Thomas S.C. Ng
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 91-97; DOI: https://doi.org/10.2967/jnumed.124.268559

Cardiovascular

  • Clinical

    • FEATURED ARTICLE OF THE MONTH

      • Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension
        You have access
        Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension
        Peng Hou, Haiming Chen, Sihao Liang, Wenliang Guo, Ruiyue Zhao, Huailu Pan, Haimin Liu, Youcai Li, Jie Lv, Kaixiang Zhong, Miao Ke, Yimin Fu, Huizhen Zhong, Xinlu Wang and Cheng Hong
        Journal of Nuclear Medicine January 1, 2025, 66 (1) 98-103; DOI: https://doi.org/10.2967/jnumed.124.268376

Pulmonary

  • Clinical

    • Comparability of Quantifying Relative Lung Ventilation with Inhaled <sup>99m</sup>Tc-Technegas and <sup>133</sup>Xe in Patients Undergoing Evaluation for Lung Transplantation
      Open Access
      Comparability of Quantifying Relative Lung Ventilation with Inhaled 99mTc-Technegas and 133Xe in Patients Undergoing Evaluation for Lung Transplantation
      Ashwin Singh Parihar, Joyce C. Mhlanga, Henry D. Royal and Barry A. Siegel
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 104-109; DOI: https://doi.org/10.2967/jnumed.124.268801

Neurology

  • Clinical

    • Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
      Open Access
      Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
      Lyduine E. Collij, Gérard N. Bischof, Daniele Altomare, Ilse Bader, Mark Battle, David Vállez García, Isadora Lopes Alves, Robin Wolz, Rossella Gismondi, Andrew Stephens, Zuzana Walker, Philip Scheltens, Agneta Nordberg, Juan Domingo Gispert, Alexander Drzezga, Andrés Perissinotti, Silvia Morbelli, Christopher Buckley, Valentina Garibotto, Giovanni B. Frisoni, Gill Farrar and Frederik Barkhof; on behalf of the AMYPAD Consortium
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 110-116; DOI: https://doi.org/10.2967/jnumed.124.268119
    • [<sup>11</sup>C]PS13 Demonstrates Pharmacologically Selective and Substantial Binding to Cyclooxygenase-1 in the Human Brain
      You have access
      [11C]PS13 Demonstrates Pharmacologically Selective and Substantial Binding to Cyclooxygenase-1 in the Human Brain
      Nafiseh Ghazanfari, Jeih-San Liow, Min-Jeong Kim, Raven Cureton, Adrian Lee, Carson Knoer, Madeline Jenkins, Jinsoo Hong, Jose A. Montero Santamaria, H. Umesha Shetty, Anthony Galassi, Paul Wighton, Martin Nørgaard, Douglas N. Greve, Sami S. Zoghbi, Victor W. Pike, Robert B. Innis and Paolo Zanotti-Fregonara
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 117-122; DOI: https://doi.org/10.2967/jnumed.124.267928
  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • Comparison Between Brain and Cerebellar Autoradiography Using [<sup>18</sup>F]Flortaucipir, [<sup>18</sup>F]MK6240, and [<sup>18</sup>F]PI2620 in Postmortem Human Brain Tissue
        You have access
        Comparison Between Brain and Cerebellar Autoradiography Using [18F]Flortaucipir, [18F]MK6240, and [18F]PI2620 in Postmortem Human Brain Tissue
        Antonio Aliaga, Joseph Therriault, Kely Monica Quispialaya, Arturo Aliaga, Robert Hopewell, Nesrine Rahmouni, Arthur C. Macedo, Peter Kunach, Jean-Paul Soucy, Gassan Massarweh, Aida Abreu Diaz, Tharick A. Pascoal, Andreia Rocha, Marie-Christine Guiot, Luiza S. Machado, Marco Antônio De Bastiani, Débora Guerini de Souza, Diogo O. Souza, Serge Gauthier, Eduardo R. Zimmer and Pedro Rosa-Neto
        Journal of Nuclear Medicine January 1, 2025, 66 (1) 123-129; DOI: https://doi.org/10.2967/jnumed.124.267539
    • Antibody-Based PET Imaging of Misfolded Superoxide Dismutase 1 in an Amyotrophic Lateral Sclerosis Mouse Model
      Open Access
      Antibody-Based PET Imaging of Misfolded Superoxide Dismutase 1 in an Amyotrophic Lateral Sclerosis Mouse Model
      Jacques A. Rousseau, Marcel Maier, Samia Ait-Mohand, Véronique Dumulon-Perreault, Otman Sarrhini, Sébastien Tremblay, Etienne Rousseau, Michael Salzmann and Brigitte Guérin
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 130-135; DOI: https://doi.org/10.2967/jnumed.124.268343
  • Translational

    • Myelin Imaging of the Spinal Cord in Animal Models and Patients with Multiple Sclerosis Using [<sup>11</sup>C]MeDAS PET: A Translational Study
      Open Access
      Myelin Imaging of the Spinal Cord in Animal Models and Patients with Multiple Sclerosis Using [11C]MeDAS PET: A Translational Study
      Chris W.J. van der Weijden, Ahmed K.M.A. Ahmed, Anouk van der Hoorn, Junqing Zhu, Chunying Wu, Yanming Wang, Gilles N. Stormezand, Rudi A.J.O. Dierckx, Jan F. Meilof and Erik F.J. de Vries
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 136-141; DOI: https://doi.org/10.2967/jnumed.123.266896
    • Effect of Acute Hypoxia Exposure on the Availability of A<sub>1</sub> Adenosine Receptors and Perfusion in the Human Brain
      You have access
      Effect of Acute Hypoxia Exposure on the Availability of A1 Adenosine Receptors and Perfusion in the Human Brain
      Manuel Michno, Jan Schmitz, Anna L. Foerges, Simone Beer, Jens Jordan, Bernd Neumaier, Alexander Drzezga, Daniel Aeschbach, Andreas Bauer, Jens Tank, Henning Weis, Eva-Maria Elmenhorst and David Elmenhorst
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 142-149; DOI: https://doi.org/10.2967/jnumed.124.268455

Physics and Instrumentation

  • Clinical

    • Quantitative Accuracy Assessment of the NeuroEXPLORER for Diverse Imaging Applications: Moving Beyond Standard Evaluations
      You have access
      Quantitative Accuracy Assessment of the NeuroEXPLORER for Diverse Imaging Applications: Moving Beyond Standard Evaluations
      Negar Omidvari, Ekaterina Shanina, Edwin K. Leung, Xishan Sun, Yusheng Li, Tim Mulnix, Paul Gravel, Shannan Henry, David Matuskey, Tommaso Volpi, Terry Jones, Ramsey D. Badawi, Hongdi Li, Richard E. Carson, Jinyi Qi and Simon R. Cherry
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 150-157; DOI: https://doi.org/10.2967/jnumed.124.268309

Highlights

  • You have access
    2024 SNMMI Highlights Lecture: General Clinical Specialties
    Twyla Bartel
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 158-161; DOI: https://doi.org/10.2967/jnumed.124.269263

The Illustrated Post

  • You have access
    Meningioma Revisited: Should Whole-Body Staging with [68Ga]Ga-DOTATOC PET/CT of High-Grade Meningiomas Become Standard Practice?
    Ekin Ermiş, Nicolas Bachmann, Katharina Lutz and Thomas Pyka
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 162; DOI: https://doi.org/10.2967/jnumed.124.267934

Departments

  • You have access
    Erratum
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 149;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 66 (1)
Journal of Nuclear Medicine
Vol. 66, Issue 1
January 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension
  • Comparison Between Brain and Cerebellar Autoradiography Using [18F]Flortaucipir, [18F]MK6240, and [18F]PI2620 in Postmortem Human Brain Tissue
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of the Art
  • Hot Topics
  • Focus on Molecular Imaging
  • Is It Really Happening?
  • Editorial
  • Oncology
    • Clinical
      • PRACTICE STANDARDS
    • Basic
  • Theranostics
    • Clinical
      • INVITED PERSPECTIVE
    • Basic
  • Radionuclide Therapy
  • Cardiovascular
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
  • Pulmonary
    • Clinical
  • Neurology
    • Clinical
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
    • Translational
  • Physics and Instrumentation
    • Clinical
  • Highlights
  • The Illustrated Post
  • Departments
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire